Moderna extends losses as Oppenheimer and Piper Sandler downgrade on valuation

seekingalpha2021-08-06

Despite better-than-expected Q2 2021 financials on Thursday, Moderna(NASDAQ:MRNA)continues to trade lower with a ~1.2% decline after Oppenheimer and Piper Sandler downgraded the stock to hold-...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • CavenW
    2021-08-06
    CavenW
    How does other vaccine stock performing? 
  • Grace87
    2021-08-06
    Grace87
    Omg
  • CHUMOI
    2021-08-06
    CHUMOI
    Ok
  • vinchoo
    2021-08-06
    vinchoo
    Hit like
  • NatYong
    2021-08-06
    NatYong
    Moderna fell nearly 2% in premarket trading.
Leave a comment
5